Two Sigma Advisers’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-155,699
| Closed | -$22.7M | – | 2424 |
|
|
2024
Q3 | $22.7M | Sell |
155,699
-129,700
| -45% | -$18.8M | 0.05% | 296 |
|
|
2024
Q2 | $39.2M | Sell |
285,399
-37,600
| -12% | -$5.02M | 0.09% | 214 |
|
|
2024
Q1 | $44.3M | Buy |
322,999
+296,400
| +1,114% | +$40.5M | 0.1% | 199 |
|
|
2023
Q4 | $3.61M | Sell |
26,599
-116,800
| -81% | -$14.3M | 0.01% | 967 |
|
|
2023
Q3 | $17.5M | Sell |
143,399
-183,100
| -56% | -$23.3M | 0.04% | 341 |
|
|
2023
Q2 | $41.5M | Buy |
326,499
+115,900
| +55% | +$15.1M | 0.11% | 199 |
|
|
2023
Q1 | $27.2M | Buy |
210,599
+158,800
| +307% | +$20.8M | 0.07% | 263 |
|
|
2022
Q4 | $6.8M | Buy |
51,799
+33,400
| +182% | +$4.32M | 0.02% | 649 |
|
|
2022
Q3 | $2.15M | Buy |
+18,399
| New | +$2.28M | 0.01% | 1136 |
|
|
2022
Q2 | – | Sell |
-104,199
| Closed | -$13.6M | – | 2754 |
|
|
2022
Q1 | $13.6M | Sell |
104,199
-291,800
| -74% | -$38M | 0.04% | 413 |
|
|
2021
Q4 | $60.4M | Sell |
395,999
-2,100
| -0.5% | -$325K | 0.15% | 134 |
|
|
2021
Q3 | $64.4M | Buy |
+398,099
| New | +$67M | 0.17% | 121 |
|
|
2020
Q1 | – | Sell |
-427,199
| Closed | -$51.5M | – | 2509 |
|
|
2019
Q4 | $51.5M | Buy |
427,199
+44,200
| +12% | +$4.93M | 0.12% | 192 |
|
|
2019
Q3 | $38.1M | Sell |
382,999
-274,000
| -42% | -$28.7M | 0.09% | 249 |
|
|
2019
Q2 | $71.7M | Buy |
656,999
+311,200
| +90% | +$33.1M | 0.18% | 144 |
|
|
2019
Q1 | $38.7M | Buy |
345,799
+155,300
| +82% | +$17M | 0.1% | 260 |
|
|
2018
Q4 | $18.4M | Buy |
190,499
+92,900
| +95% | +$9.86M | 0.05% | 407 |
|
|
2018
Q3 | $11.9M | Buy |
97,599
+50,100
| +105% | +$5.9M | 0.03% | 538 |
|
|
2018
Q2 | $5.22M | Buy |
+47,499
| New | +$5.08M | 0.01% | 834 |
|
|
2018
Q1 | – | Sell |
-312,099
| Closed | -$33.3M | – | 2342 |
|
|
2017
Q4 | $33.3M | Buy |
312,099
+294,099
| +1,634% | +$31.4M | 0.09% | 286 |
|
|
2017
Q3 | $2M | Buy |
+18,000
| New | +$1.92M | 0.01% | 1199 |
|
|
2017
Q1 | – | Sell |
-65,100
| Closed | -$5.76M | – | 2395 |
|
|
2016
Q4 | $5.76M | Buy |
+65,100
| New | +$5.92M | 0.02% | 678 |
|
|
2016
Q3 | – | Sell |
-484,200
| Closed | -$41.5M | – | 2251 |
|
|
2016
Q2 | $41.5M | Sell |
484,200
-106,500
| -18% | -$9.56M | 0.21% | 121 |
|
|
2016
Q1 | $51.4M | Buy |
+590,700
| New | +$52.8M | 0.29% | 91 |
|
|
2015
Q4 | – | Sell |
-29,700
| Closed | -$3M | – | 1932 |
|
|
2015
Q3 | $3M | Buy |
29,700
+14,100
| +90% | +$1.69M | 0.02% | 617 |
|
|
2015
Q2 | $1.92M | Buy |
+15,600
| New | +$1.87M | 0.01% | 824 |
|
Other funds holding IBB
Two Sigma Advisers's IBB Position: Q4 2024 in Review
Two Sigma Advisers sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 155,699 shares — an estimated $22.7M sold.
Two Sigma Advisers first reported a position in IBB in Q2 2015 and held it in 26 quarters. The position peaked at $71.7M in Q2 2019. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.
- Two Sigma Advisers reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
- Two Sigma Advisers sold 155,699 iShares Biotechnology ETF shares in Q4 2024, an estimated $22.7M.
- Two Sigma Advisers first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 26 quarters.
- Two Sigma Advisers's iShares Biotechnology ETF position peaked at $71.7M in Q2 2019.
- 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.
Based on Two Sigma Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.